Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients

Aldo Scarpa, William Mantovani, Paola Capelli, +7

Modern Pathology

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

Francesco Panzuto, S. Nasoni, Massimo Falconi, +12

Endocrine Related Cancer

Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression

Francesco Panzuto, Letizia Boninsegna, Nicola Fazio, +9

Journal of Clinical Oncology

Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours

Rossella Bettini, Letizia Boninsegna, William Mantovani, +7

Annals of Oncology

Prognostic FactorsPancreatic CancerPancreatic Fluid CollectionMedicineSurgical Pathology +8

Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study

Alberto Larghi, Gabriele Capurso, Antonella Carnuccio, +12

Gastrointestinal Endoscopy

Pancreatic CancerHealth SciencesKi-67 GradingHistopathologyNeuroendocrine Disorder +7

Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections

Letizia Boninsegna, Francesco Panzuto, Stefano Partelli, +6

European Journal of Cancer

Surgical OncologyPancreatic CancerMedicineSurgical PathologyNeuroendocrine Disorder +7

European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease

Simona Grozinsky‐Glasberg, Joseph Davar, Johannes Hofland, +11

Journal of Neuroendocrinology

European Neuroendocrine Tumor Society ( <scp>ENETS</scp> ) 2023 guidance paper for gastroduodenal neuroendocrine tumours ( <scp>NETs) G1–G3</scp>

Francesco Panzuto, John Ramage, D. Mark Pritchard, +6

Journal of Neuroendocrinology

Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study

Ville Sallinen, Tessa Y. S. Le Large, Elke Tieftrunk, +20

HPB

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

Francesco Panzuto, Michela Di Fonzo, Elsa Iannicelli, +11

Annals of Oncology

Surgical OncologyPancreatic CancerMedicinePharmacologyPathology +5